Opna Bio
Oncology pharmaceutical company
Epalinges, Switzerland · Founded 2018 · $38.0M raised
- Headquarters
- Epalinges
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- opnabio.com
- Total Funding
- $38.0M
- Last Round
- $38.0M Series ANov 2022
- Rounds
- 1
About
Clinical-stage biopharmaceutical company discovering and developing novel oncology therapeutics for cancer patients.
Summary
Opna Bio is a Biotech company based in Epalinges, Switzerland, founded in 2018. It has raised $38.0M in total across 1 round, most recently a $38.0M Series A round in Nov 2022. Investors include Longitude Capital, Northpond Ventures and Menlo Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...